Issue link: https://viewer.e-digitaledition.com/i/1045913
catheter. The a rms of the clip close the lea f lets of the mitra l va lve. " To place the tra nssepta l puncture exactly, we rely on the combined skills of a n inter ventiona l ca rdiolog ist , a n electrophysiolog ist a nd a n ex per t in cardiac imaging," Dr. Har vey says. " We per for m about t wo or t h ree of t hese procedures each week." A COORDINATED TEAM " WellSpan has one of the busiest struc- tura l heart programs in Pennsylvania," says Willia m Nicholson, MD, Director o f I n t e r v e n t i o n a l C a r d i o l o g y a t WellSpan Hea lth. "Electrophysiologist Br ia n Schu ler, M D, wa s responsible for bui lding the prog ra m. He ha s put together a comprehensive atria l f ibril- lation prog ra m." P a t i e n t s t y p i c a l l y f i r s t s e e Dr. Schu ler, who eva luates t hem for medica l t herapy, such a s a nticoa g u- la nts, or WATCHM A N impla ntation, Dr. Nicholson says. Dr. Schuler initiates treatment a nd g uides patients to the optima l course of treatment. " It is a g reat col laborative ef for t ," D r. N i c h o l s o n s a y s . " D r. H a r v e y, D r. S chu ler a nd I , w it h s uppor t for imag ing from Dr. Michelle Consolini, a d i a g nos t ic c a rd iolog i s t , h ave put together a strea m lined process from prepla n n ing t h roug h recover y. Th is mu lt id i s c ipl i n a r y a ppr o a c h y ie ld s excellent results." CONSTANT REFINEMENT The physicia ns at WellSpa n tra in con- tinuously to build on their a lready high level of expertise. They regularly engage in research on the most effective ways to approach structura l hea r t procedures, select i n g cl i n ica l t r ia ls d ict at ed by med ica l necessit y i n t he loca l com- munit y, according to Dr. Nicholson. " We are a lways interested in cutting- edge technolog y," he elaborates. " We wa nt t o m a ke ca re a more ef f icient process, reducing recover y times a nd ef fectively meeting the communit y 's needs. Atria l f ibrillation is a big issue ever y where, and we have ever y thing we need in York for our patients. In addition to providing high-level care, our program's research appears in multiple journals, and we're actively enrolling 10 or 20 clinical trials at any given time." TECHNOLOGICAL CONNECTIONS Wel l Spa n a dopt s new de v ic e s a nd approaches a long the same principle, sele c t i n g a c c ord i n g t o c om mu n it y need, Dr. Nicholson says. One exciting i n novation i nvolves i mpla nti ng t he WATCHMAN without the use of gen- eral anesthesia. Still in the experimental stages, the procedure was successfully performed to meet the needs of a patient who could not tolerate transesophageal echocar- diogram. Imaging was performed via echocardiogram through a vein instead. Because the patient did not need to be on a breathing machine, he underwent the procedure under only local anesthesia and recovered well, Dr. Harvey reports. PATIENT SATISFACTION G et t i n g pat ient s of f blood t h i n ners while still mitigating their risk of blood clots results in substa ntia l hea lth ben- efits. Dr. Harvey gives a telling example. "Like some hea r t medication thera- pies, the prolonged use of blood thinners ca n be problematic," he says. " T hey prevent or reduce t he risk of clots in the lef t atria l appendage, yes. But the oldest patients ca n ex perience br uis- ing on their a rms, a nd there is a risk of a life-threatening bleed in a sma l l percentage of patients." The WATCHM A N device ha s radi- ca lly improved treatment for patients in those categories. " Wit h t he WATCHM A N, a f ter t he f irst 15 or 20 procedures, we bega n to receive enormous amounts of gratitude from patients, a nd they sta r ted coming to us asking to get off their blood thin- ners — a s much for the qua lit y-of-life improvement as the sur viva l benef it," Dr. Ha r vey adds. " We a re humbled by how much we ca n positively a ffect the qua lit y of life of our patients." To learn more, visit WellSpan.org/HV. ■ " Every day, we ask, 'How can we help people?' We're proud of where we work and what we get to do for patients, and collaboration among specialties lets us do it well." — JAMES HARVEY, MD, MS, DIRECTOR OF THE STRUCTURAL HEART PROGRAM FOR WELLSPAN HEALTH The implant — which is shaped like an umbrella to capture blood clots — is inserted utilizing transseptal access and guided toward the left atrium before arriving at the opening to the left atrial appendage. The WATCHMAN left atrial appendage closure device, produced by Boston Scientific, is implanted through a simple procedure under general anesthesia. M D N E W S . C O M /// M D N E W S M I D - P E N N ■ 2 018 0 7

